GenoType® MTBDRplus compared with conventional drug-susceptibility testing of Mycobacterium tuberculosis in a low-resistance locale

Future Microbiology

Volumn 6, Issue 3, 2011, Pages 357-362

  Gitti, Zoe ^a   Mantadakis, Elpis ^b   Maraki, Sofia ^a   Samonis, George ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

ethambutol; isoniazid; molecular assays; resistance; rifampicin; TB

Indexed keywords

ISONIAZID;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE MUTATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MOLECULAR HYBRIDIZATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOTYPE; GREECE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; YOUNG ADULT;

LONCHOCARPUS GLAUCIFOLIUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 79953330171     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.11.8     Document Type: Article

References (23)

1. Perkins MD: New diagnostic tools for tuberculosis. Int. J. Tuberc. Lung Dis. 4(12 Suppl. 2), S182-S188 (2000).
2. Hillemann D, Rüsch-Gerdes S, Richter E: Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 45(8), 2635-2640 (2007).
3. Cavusoglu C, Turhan A, Akinci P et al.: Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 44(7), 2338-2342 (2006).
4. Canetti G, Fox W, Khomenko A et al.: Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull. World Health Organ. 41(1), 21-43 (1969).
5. Zhang Y, Mitchison D: The curious characteristics of pyrazinamide: a review. Int. J. Tuberc. Lung Dis. 7(1), 6-21 (2003).
6. Barnard M, Albert H, Coetzee G et al.: Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am. J. Respir. Crit. Care Med. 177(7), 787-792 (2008).
7. Nikolayevskyy V, Balabanova Y, Simak T et al.: Performance of the Genotype®MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation. BMC Clin. Pathol. 9, 2 (2009).
8. Riska PF, Jacobs WR Jr, Alland D: Molecular determinants of drug resistance in tuberculosis. Int. J. Tuberc. Lung. Dis. 4(2 Suppl. 1), S4-S10 (2000).
9. Lacoma A, Garcia-Sierra N, Prat C et al.: GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J. Clin. Microbiol. 46(11), 3660-3667 (2008).
10. Miotto P, Piana, F, Cirillo DM et al.: Genotype® MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 46(1), 393-394 (2008).
11. Aslan G, Tezcan S, Sami Serin M et al.: Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey. Jpn. J. Infect. Dis. 61(4), 255-260 (2008).
12. Steevatsan S, Pan X, Zhang Y et al.: Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob. Agents Chemother. 41(3), 600-606 (1997).
13. Hazbón MH, Bobadilla del Valle M, Guerrero MI et al.: Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob. Agents Chemother. 49(9), 3794-3802 (2005).
14. Miotto P, Piana F, Penati V et al.: Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J. Clin. Microbiol. 44(7), 2485-2491 (2006).
15. Akpaka PE, Baboolal S, Clarke D et al.: Evaluation of methods for rapid detection of resistance to isoniazid and rifampin in Mycobacterium tuberculosis isolates collected in the Caribbean. J. Clin. Microbiol. 46(10), 3426-3428 (2008).
16. Hillemann D, Weizenegger M, Kubica T et al.: Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 43(8), 3699-3703 (2005).
17. Somoskovi A, Dormandy J, Mitsani D et al.: Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. J. Clin. Microbiol. 44(12), 4459-4463 (2006).
18. Ling DI, Zwerling AA, Pai M: GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur. Respir. J. 32(5), 1165-1174 (2008). Comprehensive meta-analysis regarding the diagnostic accuracy of GenoType® MTBDR assays in detecting multidrug resistance TB.
19. Bwanga F, Hoffner S, Haile M, Joloba ML: Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect. Dis. 9, 67 (2009). Comprehensive meta-analysis regarding the diagnostic accuracy of molecular assays in detecting multidrug resistance TB.
20. Parsons LM, Salfinger M, Clobridge A et al.: Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob. Agents Chemother. 49, 2218-2225 (2005). Comprehensive and interesting study on performing and evaluating the common mutations associated with resistance to the first-line anti-TB drugs isoniazid and ethambutol.
21. Ramaswamy SV, Amin AG, Goksel S et al.: Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44(2), 326-336 (2000).
22. WHO: Drug resistance in the world. The WHO/ IUATLD global project on anti-tuberculosis drug resistance surveillance 2002-2007. Fourth global report. Geneva, Switzerland (2008) www.who.int/tb/publications/2008/drs-report4-26feb08. pdf
23. WHO: Guidelines for surveillance of drug resistance in tuberculosis. 4th edition. WHO/HTM/TB/2009.422 (2009) www.who.int/tb/publications/2009/ surveillance-guidelines/en/index.html